|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 1617 for Fasl

<< First    < Previous  |  Next >    Last >>
0.034s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Publication
10395644 | J:56128
First Author: Hashimoto W
Year: 1999
Journal: J Immunol
Title: Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
Volume: 163
Issue: 2
Pages: 583-9
•
•
•
•
•
Publication
7528774 | J:22200
First Author: Chu JL
Year: 1995
Journal: J Exp Med
Title: Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome.
Volume: 181
Issue: 1
Pages: 393-8
•
•
•
•
•
Publication
25604058 | J:232682
First Author: Levy O
Year: 2015
Journal: EMBO Mol Med
Title: Apolipoprotein E promotes subretinal mononuclear phagocyte survival and chronic inflammation in age-related macular degeneration.
Volume: 7
Issue: 2
Pages: 211-26
•
•
•
•
•
Publication
23922974 | J:204362
First Author: Krzyzowska M
Year: 2013
Journal: PLoS One
Title: HSV-2 regulates monocyte inflammatory response via the Fas/FasL pathway.
Volume: 8
Issue: 7
Pages: e70308
•
•
•
•
•
Publication
7530197 | J:22518
First Author: Watanabe D
Year: 1995
Journal: EMBO J
Title: Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders.
Volume: 14
Issue: 1
Pages: 12-8
•
•
•
•
•
Publication
26444718 | J:231062
First Author: Rogge M
Year: 2015
Journal: Invest Ophthalmol Vis Sci
Title: Therapeutic Use of Soluble Fas Ligand Ameliorates Acute and Recurrent Herpetic Stromal Keratitis in Mice.
Volume: 56
Issue: 11
Pages: 6377-86
•
•
•
•
•
Publication
19654302 | J:151764
First Author: Shanker A
Year: 2009
Journal: Cancer Res
Title: Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicity.
Volume: 69
Issue: 16
Pages: 6615-23
•
•
•
•
•
Publication
34223817 | J:310621
   
First Author: Jeong D
Year: 2021
Journal: Elife
Title: Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2.
Volume: 10
•
•
•
•
•
Publication
15148335 | J:114948
First Author: Hao Z
Year: 2004
Journal: J Exp Med
Title: T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis.
Volume: 199
Issue: 10
Pages: 1355-65
•
•
•
•
•
Publication
25873756 | J:331860
 
First Author: Bień K
Year: 2015
Journal: Mediators Inflamm
Title: Fas/FasL pathway participates in regulation of antiviral and inflammatory response during mousepox infection of lungs.
Volume: 2015
Pages: 281613
•
•
•
•
•
Publication
30429213 | J:271164
First Author: Xiao W
Year: 2019
Journal: Mol Cancer Res
Title: Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy.
Volume: 17
Issue: 2
Pages: 420-430
•
•
•
•
•
Publication
15743781 | J:96722
First Author: Neff TA
Year: 2005
Journal: Am J Pathol
Title: Relationship of acute lung inflammatory injury to Fas/FasL system.
Volume: 166
Issue: 3
Pages: 685-94
•
•
•
•
•
Publication
19740996 | J:153977
First Author: Ishikawa T
Year: 2009
Journal: J Virol
Title: Protective role of Fas-FasL signaling in lethal infection with herpes simplex virus type 2 in mice.
Volume: 83
Issue: 22
Pages: 11777-83
•
•
•
•
•
Publication
10209037 | J:54478
First Author: Sabelko-Downes KA
Year: 1999
Journal: J Exp Med
Title: Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis.
Volume: 189
Issue: 8
Pages: 1195-205
•
•
•
•
•
Publication
10209045 | J:54480
First Author: Hill LL
Year: 1999
Journal: J Exp Med
Title: A critical role for Fas ligand in the active suppression of systemic immune responses by ultraviolet radiation.
Volume: 189
Issue: 8
Pages: 1285-94
•
•
•
•
•
Publication
11086022 | J:115110
First Author: Song J
Year: 2000
Journal: J Clin Invest
Title: Roles of Fas and Fas ligand during mammary gland remodeling.
Volume: 106
Issue: 10
Pages: 1209-20
•
•
•
•
•
Publication
16527892 | J:135682
First Author: Liu Y
Year: 2006
Journal: Blood
Title: Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo.
Volume: 108
Issue: 1
Pages: 123-33
•
•
•
•
•
Publication
18292515 | J:131560
First Author: Dudani R
Year: 2008
Journal: J Immunol
Title: Mutation in the Fas pathway impairs CD8+ T cell memory.
Volume: 180
Issue: 5
Pages: 2933-41
•
•
•
•
•
Publication
25744024 | J:258989
First Author: Wang L
Year: 2015
Journal: Cell Death Differ
Title: Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass.
Volume: 22
Issue: 10
Pages: 1654-64
•
•
•
•
•
Publication
9915863 | J:115231
First Author: Mittelstadt PR
Year: 1999
Journal: J Biol Chem
Title: Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells.
Volume: 274
Issue: 5
Pages: 3222-7
•
•
•
•
•
Publication
20971954 | J:168406
First Author: Lückerath K
Year: 2011
Journal: Blood
Title: Immune modulation by Fas ligand reverse signaling: lymphocyte proliferation is attenuated by the intracellular Fas ligand domain.
Volume: 117
Issue: 2
Pages: 519-29
•
•
•
•
•
Publication
18219273 | J:131818
First Author: Krum SA
Year: 2008
Journal: EMBO J
Title: Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival.
Volume: 27
Issue: 3
Pages: 535-45
•
•
•
•
•
Publication
22156346 | J:180882
First Author: Morris JE
Year: 2012
Journal: J Immunol
Title: Mice with mutations in Fas and Fas ligand demonstrate increased herpetic stromal keratitis following corneal infection with HSV-1.
Volume: 188
Issue: 2
Pages: 793-9
•
•
•
•
•
Publication
16114107 | J:113493
First Author: Stuart PM
Year: 2005
Journal: Eur J Immunol
Title: The role of Fas ligand as an effector molecule in corneal graft rejection.
Volume: 35
Issue: 9
Pages: 2591-7
•
•
•
•
•
Publication
11067900 | J:119582
First Author: Wahlsten JL
Year: 2000
Journal: J Immunol
Title: Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis.
Volume: 165
Issue: 10
Pages: 5480-6
•
•
•
•
•
Publication
8921411 | J:42521
First Author: Seino K
Year: 1996
Journal: Int Immunol
Title: Contribution of Fas ligand to cardiac allograft rejection.
Volume: 8
Issue: 9
Pages: 1347-54
•
•
•
•
•
Publication
10620607 | J:59244
First Author: Körner H
Year: 2000
Journal: J Exp Med
Title: Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype.
Volume: 191
Issue: 1
Pages: 89-96
•
•
•
•
•
Publication
11581190 | J:72055
First Author: Nguyen QD
Year: 2001
Journal: Invest Ophthalmol Vis Sci
Title: Effect of Fas and Fas ligand deficiency in resistance of C57BL/6 mice to HSV-1 keratitis and chorioretinitis.
Volume: 42
Issue: 11
Pages: 2505-9
•
•
•
•
•
Publication
9379003 | J:43938
First Author: Weintraub JP
Year: 1997
Journal: J Immunol
Title: Up-regulation of Fas and the costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/gld mice.
Volume: 159
Issue: 8
Pages: 4117-26
•
•
•
•
•
Publication
18192669 | J:131293
First Author: Cretney E
Year: 2008
Journal: Int Immunol
Title: No requirement for TRAIL in intrathymic negative selection.
Volume: 20
Issue: 2
Pages: 267-76
•
•
•
•
•
Publication
9126971 | J:39792
First Author: Hunt JS
Year: 1997
Journal: J Immunol
Title: Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus.
Volume: 158
Issue: 9
Pages: 4122-8
•
•
•
•
•
Publication
15972636 | J:100620
First Author: Fields ML
Year: 2005
Journal: J Immunol
Title: The influence of effector T cells and Fas ligand on lupus-associated B cells.
Volume: 175
Issue: 1
Pages: 104-11
•
•
•
•
•
Publication
16618773 | J:108303
First Author: Torrero MN
Year: 2006
Journal: Cancer Res
Title: Stat1 deficiency in the host enhances interleukin-12-mediated tumor regression.
Volume: 66
Issue: 8
Pages: 4461-7
•
•
•
•
•
Publication
32686739 | J:359888
First Author: Kim HN
Year: 2020
Journal: Sci Rep
Title: Estrogens decrease osteoclast number by attenuating mitochondria oxidative phosphorylation and ATP production in early osteoclast precursors.
Volume: 10
Issue: 1
Pages: 11933
•
•
•
•
•
Publication
10919598 | J:63433
First Author: van den Brink MR
Year: 2000
Journal: Transplantation
Title: Fas ligand-deficient gld mice are more susceptible to graft-versus-host-disease.
Volume: 70
Issue: 1
Pages: 184-91
•
•
•
•
•
Publication
19104149 | J:144702
First Author: Brochard V
Year: 2009
Journal: J Clin Invest
Title: Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.
Volume: 119
Issue: 1
Pages: 182-92
•
•
•
•
•
Publication
15972635 | J:100624
First Author: Camacho IA
Year: 2005
Journal: J Immunol
Title: Treatment of mice with 2,3,7,8-tetrachlorodibenzo-p-dioxin leads to aryl hydrocarbon receptor-dependent nuclear translocation of NF-kappaB and expression of Fas ligand in thymic stromal cells and consequent apoptosis in T cells.
Volume: 175
Issue: 1
Pages: 90-103
•
•
•
•
•
Publication
23164664 | J:193201
First Author: Fullerton AM
Year: 2013
Journal: Toxicol Appl Pharmacol
Title: 2,3,7,8-TCDD enhances the sensitivity of mice to concanavalin A immune-mediated liver injury.
Volume: 266
Issue: 2
Pages: 317-27
•
•
•
•
•
Publication
19234198 | J:146241
First Author: Olson MR
Year: 2009
Journal: J Immunol
Title: Fas ligand is required for the development of respiratory syncytial virus vaccine-enhanced disease.
Volume: 182
Issue: 5
Pages: 3024-31
•
•
•
•
•
Publication
16606788 | J:121665
First Author: Matter CM
Year: 2006
Journal: Circulation
Title: Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation.
Volume: 113
Issue: 15
Pages: 1879-87
•
•
•
•
•
Publication
15814689 | J:98158
First Author: Vacchio MS
Year: 2005
Journal: J Immunol
Title: Fetal expression of Fas ligand is necessary and sufficient for induction of CD8 T cell tolerance to the fetal antigen H-Y during pregnancy.
Volume: 174
Issue: 8
Pages: 4657-61
•
•
•
•
•
Publication
29889098 | J:265443
First Author: Mande P
Year: 2018
Journal: J Clin Invest
Title: Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation.
Volume: 128
Issue: 7
Pages: 2966-2978
•
•
•
•
•
Publication
15466930 | J:98137
First Author: Maeda Y
Year: 2005
Journal: Blood
Title: Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease.
Volume: 105
Issue: 5
Pages: 2023-7
•
•
•
•
•
Publication
20164456 | J:164101
First Author: Roychoudhury J
Year: 2010
Journal: Invest Ophthalmol Vis Sci
Title: Targeting immune privilege to prevent pathogenic neovascularization.
Volume: 51
Issue: 7
Pages: 3560-6
•
•
•
•
•
Publication
16002674 | J:100709
First Author: Litzinger MT
Year: 2005
Journal: J Immunol
Title: Mechanisms of gene therapy for tolerance: B7 signaling is required for peptide-IgG gene-transferred tolerance induction.
Volume: 175
Issue: 2
Pages: 780-7
•
•
•
•
•
Publication
23918976 | J:205801
First Author: Bossaller L
Year: 2013
Journal: J Immunol
Title: Overexpression of membrane-bound fas ligand (CD95L) exacerbates autoimmune disease and renal pathology in pristane-induced lupus.
Volume: 191
Issue: 5
Pages: 2104-14
•
•
•
•
•
Publication
9933089 | J:82109
First Author: Lopes MF
Year: 1999
Journal: Eur J Immunol
Title: Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response.
Volume: 29
Issue: 1
Pages: 81-9
•
•
•
•
•
Publication
9776707 | J:49861
First Author: Hong NM
Year: 1998
Journal: J Autoimmun
Title: Amelioration of lymphoid hyperplasia and hypergammaglobulinemia in lupus-prone mice (gld) by Fas-ligand gene transfer.
Volume: 11
Issue: 4
Pages: 301-7
•
•
•
•
•
Publication
24401839 | J:232301
First Author: Chen C
Year: 2014
Journal: EMBO Mol Med
Title: Telomerase governs immunomodulatory properties of mesenchymal stem cells by regulating FAS ligand expression.
Volume: 6
Issue: 3
Pages: 322-34
•
•
•
•
•
Publication
17339432 | J:144295
First Author: Kovacić N
Year: 2007
Journal: J Immunol
Title: The Fas/Fas ligand system inhibits differentiation of murine osteoblasts but has a limited role in osteoblast and osteoclast apoptosis.
Volume: 178
Issue: 6
Pages: 3379-89
•
•
•
•
•
Publication
21718680 | J:174384
First Author: Xiao Z
Year: 2011
Journal: Am J Pathol
Title: Inhibition of Fas ligand in NOD mice unmasks a protective role for IL-10 against insulitis development.
Volume: 179
Issue: 2
Pages: 725-32
•
•
•
•
•
Publication
22815291 | J:189732
First Author: Kish DD
Year: 2012
Journal: J Immunol
Title: Neutrophil expression of Fas ligand and perforin directs effector CD8 T cell infiltration into antigen-challenged skin.
Volume: 189
Issue: 5
Pages: 2191-202
•
•
•
•
•
Publication
19855087 | J:175438
First Author: Tong J
Year: 2010
Journal: Am J Respir Cell Mol Biol
Title: Fas ligand expression on T cells is sufficient to prevent prolonged airway inflammation in a murine model of asthma.
Volume: 43
Issue: 3
Pages: 342-8
•
•
•
•
•
Publication
18566384 | J:137178
First Author: Zhang Y
Year: 2008
Journal: J Immunol
Title: Th17 cells undergo Fas-mediated activation-induced cell death independent of IFN-gamma.
Volume: 181
Issue: 1
Pages: 190-6
•
•
•
•
•
Publication
17591956 | J:122836
First Author: Wesche-Soldato DE
Year: 2007
Journal: Am J Pathol
Title: CD8+ T cells promote inflammation and apoptosis in the liver after sepsis: role of Fas-FasL.
Volume: 171
Issue: 1
Pages: 87-96
•
•
•
•
•
Publication
17363561 | J:120309
First Author: Qi CF
Year: 2007
Journal: Cancer Res
Title: Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells.
Volume: 67
Issue: 6
Pages: 2439-47
•
•
•
•
•
Publication
31066896 | J:277771
First Author: Xiao B
Year: 2019
Journal: Biol Reprod
Title: Restraint stress of male mice induces apoptosis in spermatozoa and spermatogenic cells: role of the FasL/Fas system†.
Volume: 101
Issue: 1
Pages: 235-247
•
•
•
•
•
Publication
17052246 | J:122316
First Author: Cone RE
Year: 2007
Journal: Immunology
Title: The suppression of delayed-type hypersensitivity by CD8+ regulatory T cells requires interferon-gamma.
Volume: 120
Issue: 1
Pages: 112-9
•
•
•
•
•
Publication
18000953 | J:128537
First Author: He KM
Year: 2007
Journal: Eur J Immunol
Title: Donor double-negative Treg promote allogeneic mixed chimerism and tolerance.
Volume: 37
Issue: 12
Pages: 3455-66
•
•
•
•
•
Publication
16539627 | J:135761
First Author: Niederkorn JY
Year: 2006
Journal: Am J Transplant
Title: Differential roles of CD8+ and CD8- T lymphocytes in corneal allograft rejection in 'high-risk' hosts.
Volume: 6
Issue: 4
Pages: 705-13
•
•
•
•
•
Publication
16428764 | J:104991
First Author: Shi C
Year: 2006
Journal: Infect Immun
Title: Fas ligand deficiency impairs host inflammatory response against infection with the spirochete Borrelia burgdorferi.
Volume: 74
Issue: 2
Pages: 1156-60
•
•
•
•
•
Publication
11536159 | J:71678
First Author: Vallabhapurapu S
Year: 2001
Journal: Eur J Immunol
Title: Inhibition of NF-kappaB in T cells blocks lymphoproliferation and partially rescues autoimmune disease in gld/gld mice.
Volume: 31
Issue: 9
Pages: 2612-22
•
•
•
•
•
Publication
22573809 | J:188880
First Author: Cai Z
Year: 2012
Journal: J Immunol
Title: Activated T cell exosomes promote tumor invasion via Fas signaling pathway.
Volume: 188
Issue: 12
Pages: 5954-61
•
•
•
•
•
Publication
15322205 | J:92711
First Author: Rutigliano JA
Year: 2004
Journal: J Immunol
Title: Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection.
Volume: 173
Issue: 5
Pages: 3408-17
•
•
•
•
•
Publication
23569113 | J:199517
First Author: Sugi N
Year: 2013
Journal: Infect Immun
Title: Increased resistance to Staphylococcus aureus endophthalmitis in BALB/c mice: Fas ligand is required for resolution of inflammation but not for bacterial clearance.
Volume: 81
Issue: 6
Pages: 2217-25
•
•
•
•
•
Publication
15583018 | J:94696
First Author: Zhang JQ
Year: 2004
Journal: J Exp Med
Title: Evidence for selective transformation of autoreactive immature plasma cells in mice deficient in Fasl.
Volume: 200
Issue: 11
Pages: 1467-78
•
•
•
•
•
Publication
22205032 | J:180753
First Author: Xu X
Year: 2012
Journal: J Immunol
Title: Splenic stroma-educated regulatory dendritic cells induce apoptosis of activated CD4 T cells via Fas ligand-enhanced IFN-γ and nitric oxide.
Volume: 188
Issue: 3
Pages: 1168-77
•
•
•
•
•
Publication
22461695 | J:331309
First Author: Yang D
Year: 2012
Journal: J Immunol
Title: Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo.
Volume: 188
Issue: 9
Pages: 4441-9
•
•
•
•
•
Publication
10792025 | J:62215
First Author: Takeda K
Year: 2000
Journal: Proc Natl Acad Sci U S A
Title: Critical contribution of liver natural killer T cells to a murine model of hepatitis.
Volume: 97
Issue: 10
Pages: 5498-503
•
•
•
•
•
Publication
12960267 | J:85969
First Author: Kafrouni MI
Year: 2003
Journal: J Leukoc Biol
Title: The role of TNF-TNFR2 interactions in generation of CTL responses and clearance of hepatic adenovirus infection.
Volume: 74
Issue: 4
Pages: 564-71
•
•
•
•
•
Publication
9155013 | J:40025
First Author: Cheng LE
Year: 1997
Journal: EMBO J
Title: Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis.
Volume: 16
Issue: 8
Pages: 1865-75
•
•
•
•
•
Publication
11981816 | J:76540
First Author: Tourneur L
Year: 2002
Journal: Eur J Immunol
Title: IL-10 is necessary for FasL-induced protection from experimental autoimmune thyroiditis but not for FasL-induced immune deviation.
Volume: 32
Issue: 5
Pages: 1292-9
•
•
•
•
•
Publication
11922619 | J:75884
First Author: Mu J
Year: 2002
Journal: Biochem Biophys Res Commun
Title: Apoptosis and related proteins during parturition in prostaglandin F receptor-deficient mice.
Volume: 292
Issue: 3
Pages: 675-81
•
•
•
•
•
Publication
16581901 | J:108289
First Author: Raoul C
Year: 2006
Journal: Proc Natl Acad Sci U S A
Title: Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL.
Volume: 103
Issue: 15
Pages: 6007-12
•
•
•
•
•
Publication
26232171 | J:226422
First Author: Schleicher RI
Year: 2015
Journal: Blood
Title: Platelets induce apoptosis via membrane-bound FasL.
Volume: 126
Issue: 12
Pages: 1483-93
•
•
•
•
•
Publication
17182568 | J:141930
First Author: Manicassamy S
Year: 2007
Journal: J Immunol
Title: The critical role of protein kinase C-theta in Fas/Fas ligand-mediated apoptosis.
Volume: 178
Issue: 1
Pages: 312-9
•
•
•
•
•
Publication
23011975 | J:191108
First Author: Wang X
Year: 2013
Journal: Eur J Immunol
Title: Astrocytic Fas ligand expression is required to induce T-cell apoptosis and recovery from experimental autoimmune encephalomyelitis.
Volume: 43
Issue: 1
Pages: 115-24
•
•
•
•
•
Publication
31552143 | J:281978
 
First Author: Trivedi PM
Year: 2019
Journal: Cell Death Discov
Title: Soluble FAS ligand is not required for pancreatic islet inflammation or beta-cell destruction in non-obese diabetic mice.
Volume: 5
Pages: 136
•
•
•
•
•
Publication
26582200 | J:230059
First Author: Urresti J
Year: 2016
Journal: J Biol Chem
Title: Lifeguard Inhibits Fas Ligand-mediated Endoplasmic Reticulum-Calcium Release Mandatory for Apoptosis in Type II Apoptotic Cells.
Volume: 291
Issue: 3
Pages: 1221-34
•
•
•
•
•
Publication
20404348 | J:224737
First Author: Sayed D
Year: 2010
Journal: J Biol Chem
Title: MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand.
Volume: 285
Issue: 26
Pages: 20281-90
•
•
•
•
•
Publication
14560009 | J:242476
First Author: Droin NM
Year: 2003
Journal: Mol Cell Biol
Title: Egr family members regulate nonlymphoid expression of Fas ligand, TRAIL, and tumor necrosis factor during immune responses.
Volume: 23
Issue: 21
Pages: 7638-47
•
•
•
•
•
Publication
11792426 | J:74259
First Author: Motegi-Ishiyama Y
Year: 2002
Journal: Mol Immunol
Title: Porcine Fas-ligand gene: genomic sequence analysis and comparison with human gene.
Volume: 38
Issue: 8
Pages: 581-6
•
•
•
•
•
Publication
10657610 | J:60397
First Author: Batteux F
Year: 2000
Journal: J Immunol
Title: Transgenic expression of Fas ligand on thyroid follicular cells prevents autoimmune thyroiditis.
Volume: 164
Issue: 4
Pages: 1681-8
•
•
•
•
•
Publication
8603437 | J:31276
First Author: Cui H
Year: 1996
Journal: Cell Immunol
Title: Regulation of T-cell death genes: selective inhibition of FasL- but not Fas-mediated function.
Volume: 167
Issue: 2
Pages: 276-84
•
•
•
•
•
Publication
8609166 | J:32512
First Author: French LE
Year: 1996
Journal: J Cell Biol
Title: Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover.
Volume: 133
Issue: 2
Pages: 335-43
•
•
•
•
•
Publication
9829839 | J:51173
First Author: Shimizu M
Year: 1998
Journal: Cancer Immunol Immunother
Title: Antitumor activity exhibited by Fas ligand (CD95L) overexpressed on lymphoid cells against Fas+ tumor cells.
Volume: 47
Issue: 3
Pages: 143-8
•
•
•
•
•
Publication
15052663 | J:91310
First Author: Sharma PR
Year: 2004
Journal: Anat Rec A Discov Mol Cell Evol Biol
Title: Spatiotemporal analysis of programmed cell death during mouse cardiac septation.
Volume: 277
Issue: 2
Pages: 355-69
•
•
•
•
•
Publication
15237105 | J:91539
First Author: Umemura M
Year: 2004
Journal: Int Immunol
Title: Involvement of IL-17 in Fas ligand-induced inflammation.
Volume: 16
Issue: 8
Pages: 1099-108
•
•
•
•
•
Publication
14734739 | J:87695
First Author: Roth E
Year: 2004
Journal: J Immunol
Title: IFN-gamma promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells.
Volume: 172
Issue: 3
Pages: 1588-94
•
•
•
•
•
Publication
15356111 | J:92754
First Author: Dalton JE
Year: 2004
Journal: J Immunol
Title: Fas-Fas ligand interactions are essential for the binding to and killing of activated macrophages by gamma delta T cells.
Volume: 173
Issue: 6
Pages: 3660-7
•
•
•
•
•
Publication
16204241 | J:104105
First Author: Baum W
Year: 2005
Journal: J Biol Chem
Title: Binding of the intracellular Fas ligand (FasL) domain to the adaptor protein PSTPIP results in a cytoplasmic localization of FasL.
Volume: 280
Issue: 48
Pages: 40012-24
•
•
•
•
•
Publication
16301623 | J:122147
First Author: Park H
Year: 2005
Journal: J Immunol
Title: Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis.
Volume: 175
Issue: 11
Pages: 7193-201
•
•
•
•
•
Publication
12734343 | J:123908
First Author: Silva DG
Year: 2003
Journal: J Immunol
Title: Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.
Volume: 170
Issue: 10
Pages: 4996-5002
•
•
•
•
•
Publication
12454289 | J:125415
First Author: Pinkoski MJ
Year: 2002
Journal: Proc Natl Acad Sci U S A
Title: Nonlymphoid Fas ligand in peptide-induced peripheral lymphocyte deletion.
Volume: 99
Issue: 25
Pages: 16174-9
•
•
•
•
•
Publication
12576484 | J:134983
First Author: Yang J
Year: 2003
Journal: J Biol Chem
Title: Endothelial cell overexpression of fas ligand attenuates ischemia-reperfusion injury in the heart.
Volume: 278
Issue: 17
Pages: 15185-91
•
•
•
•
•
Publication
19955659 | J:156723
First Author: Na IK
Year: 2010
Journal: J Clin Invest
Title: The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.
Volume: 120
Issue: 1
Pages: 343-56
•
•
•
•
•
Publication
19949088 | J:159008
First Author: Zou Y
Year: 2010
Journal: J Immunol
Title: Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure.
Volume: 184
Issue: 1
Pages: 466-75
•
•
•
•
•
Publication
19949069 | J:159432
First Author: He JS
Year: 2010
Journal: J Immunol
Title: Stored Fas ligand, a mediator of rapid CTL-mediated killing, has a lower threshold for response than degranulation or newly synthesized Fas ligand.
Volume: 184
Issue: 2
Pages: 555-63
•
•
•
•
•
Publication
21114495 | J:170249
First Author: Choi K
Year: 2011
Journal: J Neurochem
Title: Fas ligation and tumor necrosis factor α activation of murine astrocytes promote heat shock factor-1 activation and heat shock protein expression leading to chemokine induction and cell survival.
Volume: 116
Issue: 3
Pages: 438-48
•
•
•
•
•
Publication
22751926 | J:188805
First Author: Anathy V
Year: 2012
Journal: Mol Cell Biol
Title: Oxidative processing of latent Fas in the endoplasmic reticulum controls the strength of apoptosis.
Volume: 32
Issue: 17
Pages: 3464-78
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom